α-Particle Radioimmunotherapy of Disseminated Peritoneal Disease Using a 212Pb-Labeled Radioimmunoconjugate Targeting HER2-Reference-Cited by-同舟云学术

α-Particle Radioimmunotherapy of Disseminated Peritoneal Disease Using a 212Pb-Labeled Radioimmunoconjugate Targeting HER2

Published:2005-10 Issue:5 Volume:20 Page:557-568
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Milenic Diane E.¹,Garmestani Kayhan¹,Brady Erik D.¹,Albert Paul S.²,Ma Dangshe¹,Abdulla Alia¹,Brechbiel Martin W.¹

Affiliation:

1. Radioimmune and Inorganic Chemistry Section, Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda MD.

2. Biometric Research Branch, National Cancer Institute, Bethesda, MD.

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/cbr.2005.20.557

Reference41 articles.

1. 212Bismuth Linked to an Antipancreatic Carcinoma Antibody: Model for Alpha-Particle-Emitter Radioimmunotherapy

2. Vascular-Targeted Radioimmunotherapy with the Alpha-Particle Emitter211At

3. Delivery of the α-emitting radioisotope bismuth-213 to solid tumors via single-chain Fv and diabody molecules

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Method and mechanism for efficient radium isolation from bulk thorium based on anion exchange;Chemical Engineering Journal;2024-09

2. Lead‐212/Bismuth‐212 In Vivo Generator Based on Ultrasmall Silver Telluride Nanoparticles;Journal of Labelled Compounds and Radiopharmaceuticals;2024-08-15

3. Targeted Radium Alpha Therapy in the Era of Nanomedicine: In Vivo Results;International Journal of Molecular Sciences;2024-01-04

4. First experience with 224Radium-labeled microparticles (Radspherin®) after CRS-HIPEC for peritoneal metastasis in colorectal cancer (a phase 1 study);Frontiers in Medicine;2023-03-01

5. Delivery of radiopharmaceuticals and theranostic agents: targeted alpha therapy;Novel Platforms for Drug Delivery Applications;2023